| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/02/1994 | EP0584348A1 Genetic vaccine for immunodeficiency viruses |
| 03/02/1994 | EP0584347A1 Enantiomeric hydroxylated xanthine compounds |
| 03/02/1994 | EP0584284A1 Recombinant dna-derived cholera toxin subunit analogs |
| 03/02/1994 | EP0584208A1 Pyrrolidinones |
| 03/02/1994 | EP0584085A1 Antibiotic carbapenem derivatives |
| 03/02/1994 | EP0402378B1 Conjugation of polymer to colony stimulating factor-1 |
| 03/02/1994 | CN1083073A Novel lipophilic oligopeptides with immunomodulating activity |
| 03/02/1994 | CN1083068A Derivatives of 16-membered ring antibiotic macrolides |
| 03/02/1994 | CN1083064A Substituted indolizino Û1,2-6Ù quinolinones |
| 03/02/1994 | CN1083053A Quinoline and naphthyridine prodrugs |
| 03/02/1994 | CN1083047A Novel method of producing 7-(substituted)-9-|(substituted glycyl)-amido¨-6-demethyl-6-deoxytetra-cyclines |
| 03/02/1994 | CN1082923A Process for attenuated varicella zoster virus vaccine production |
| 03/02/1994 | CN1082895A Pharmaceutical compositions for the treatment of hepatitis B virus (HBV) infection |
| 03/02/1994 | CN1082894A Antiviral pharmaceutical compositions for vaginal administration |
| 03/02/1994 | CN1082892A Antiviral agents |
| 03/02/1994 | CN1023901C Novel family of primate hematopoietic growth factors |
| 03/02/1994 | CA2091004A1 .alpha.-d-glycosyl kasugamycin, its preparation, and antibacterial agent containing the same |
| 03/01/1994 | US5290929 Heteroaryl derivatives of monocyclic beta-lactam antibiotics |
| 03/01/1994 | US5290794 Soluble calcium lactate antibacterial complexes as non-irritating parenteral forms |
| 03/01/1994 | US5290571 Undenatured whey protein providing Vitamins B1 and B2 |
| 03/01/1994 | CA1327357C Antiviral, antitumor and antifungal compositions and their methods of use |
| 03/01/1994 | CA1327332C Animal derived cell with antigenic protein introduced therein |
| 02/26/1994 | CA2104764A1 Method for the safe administration of fatty acids |
| 02/26/1994 | CA2104747A1 Method for the safe administration of fatty acids |
| 02/23/1994 | EP0584014A1 Pradimicin compounds |
| 02/23/1994 | EP0583806A1 Acrylic derivatives of 2-thiazolypyrroles having a fungicidal activity |
| 02/23/1994 | EP0583794A1 Recombinant pseudomonas exotoxin: construction of an active immunotoxin with low side effects |
| 02/23/1994 | EP0583414A1 Erythromycin derivatives |
| 02/23/1994 | EP0583360A1 Compositions for the prevention and/or treatment of pathological processes |
| 02/23/1994 | EP0583358A1 Partial liquid breathing of fluorocarbons |
| 02/23/1994 | EP0583357A1 Glycine anhydride dimethylol as a biocide and preservative |
| 02/23/1994 | EP0583317A1 Dibenzothiazepinthione as antiviral agents |
| 02/23/1994 | EP0583288A1 Antivizal dibenzothiazepinone derivatives |
| 02/23/1994 | EP0583274A1 Use of a 1,3-oxathiolan derivative for the treatment of hepatitis b infection |
| 02/23/1994 | CN1023858C Pesticide composition containing macrolide compound and its making method |
| 02/22/1994 | US5288709 Erythromycin derivatives |
| 02/22/1994 | US5288704 Synergistic composition comprising a fibroblast growth factor and a sulfated polysaccharide, for use as antiviral agent |
| 02/22/1994 | US5288693 2-(3-oxoalk(en)yl)-3-isothiazolones and derivatives as antimicrobial agents |
| 02/22/1994 | CA1327198C Quinolonecarboxylic acid derivatives and their preparation |
| 02/17/1994 | WO1994003621A1 Vector vaccines of recombinant feline herpesvirus |
| 02/17/1994 | WO1994003620A2 Method of increasing expression of viral proteins |
| 02/17/1994 | WO1994003595A1 Non-shedding live herpesvirus vaccine |
| 02/17/1994 | WO1994003589A2 Hepatitis a virus vaccine |
| 02/17/1994 | WO1994003490A1 Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the e1 and e2 protein of rubella virus |
| 02/17/1994 | WO1994003467A2 Antiretroviral enantiomeric nucleotide analogs |
| 02/17/1994 | WO1994003465A1 Liponucleotides of seco-nucleosides, their preparation and their use as anti-viral drugs |
| 02/17/1994 | WO1994003451A1 Quinuclidine derivatives as squalene synthase inhibitors |
| 02/17/1994 | WO1994003450A1 Furylthiazole and their use as h2-receptor antagonists and antimicrobial agents |
| 02/17/1994 | WO1994003440A1 Benzoxazinones as inhibitors of hiv reverse transcriptase |
| 02/17/1994 | WO1994003427A1 2-thioindoles (selenoindoles) and related disulfides (selenides) which inhibit protein tyrosine kinases and which have antitumor properties |
| 02/17/1994 | WO1994003207A1 Herpesvirus vaccines |
| 02/17/1994 | WO1994003206A1 Tetanus vaccine production |
| 02/17/1994 | WO1994003205A1 Hla binding peptides and their uses |
| 02/17/1994 | WO1994003191A1 NON-PEPTIDYL MOIETY-CONJUGATED CD4-GAMMA2 AND CD4-IgG2 IMMUNOCONJUGATES, AND USES THEREOF |
| 02/17/1994 | WO1994003178A1 Therapeutic use of phosphoryl-l-serine-n-acyl-sphingosine |
| 02/17/1994 | WO1994003174A1 Treatment of dentoalveolar infections with taurolidine and/or taurultam |
| 02/17/1994 | WO1994003163A1 Use of 2-(4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone for the treatment of cancer |
| 02/17/1994 | WO1994000586A3 Infectious bovine rhinotracheitis virus mutants and vaccines |
| 02/17/1994 | WO1994000555A3 Compositions for the inhibition of protein hormone formation and uses thereof |
| 02/17/1994 | WO1993018054A3 Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them |
| 02/17/1994 | CA2141960A1 Hla binding peptides and their uses |
| 02/17/1994 | CA2141806A1 Quinuclidine derivatives as squalene synthase inhibitors |
| 02/17/1994 | CA2141673A1 Non-peptidyl moiety-conjugated cd4-gamma2 and cd4-igg2 immunoconjugates, and uses thereof |
| 02/17/1994 | CA2141557A1 Therapeutic use of phosphoryl-l-serine-n-acyl-sphingosine |
| 02/17/1994 | CA2141274A1 Use of 2-(4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1, 4- naphthoquinone for the treatment of cancer |
| 02/17/1994 | CA2140440A1 2-thioindoles (selenoindoles) and related disulfides (selenides) which inhibit protein tyrosine kinases and which have antitumor properties |
| 02/16/1994 | EP0583161A2 4-Aminopyrrole-2-carboxamide derivatives as antiviral agents |
| 02/16/1994 | EP0583142A2 Hepatitis A virus vaccine |
| 02/16/1994 | EP0582829A1 9-(substituted glycyl) amido - 6-demethyl-6-deoxytetracyclines as antibiotic agents |
| 02/16/1994 | EP0582810A1 Novel 7-(substituted)-8-(substituted)-9-(substituted amino)-6-demethyl-6-deoxyetracyclines as antibiotic agents |
| 02/16/1994 | EP0582790A1 Novel method of producing 7-(substituted)-9- (substituted glycyl)amido -6-demethyl-6-deoxytetracyclines |
| 02/16/1994 | EP0582789A1 Novel 7-(substituted)-8-(substituted)-9- (substituted glycyl)amido -6-demethyl-6-deoxytetracyclines |
| 02/16/1994 | EP0582788A1 7-(Substituted)-9- (substituted glycyl)-amido)-6-demethyl-6-deoxytetracyclines |
| 02/16/1994 | EP0582672A1 Methods to detect and treat diseases caused by bacterial allergens |
| 02/16/1994 | EP0582630A1 N?6 -(hydrazinoiminomethyl)lysine and method of inhibiting nitric oxide formation in body |
| 02/16/1994 | EP0582581A1 1-SUBSTITUTED, 2-SUBSTITUTED 1H-IMIDAZO 4,5-c]QUINOLIN-4-AMINES |
| 02/16/1994 | CN1082053A Synthetic polypeptides |
| 02/16/1994 | CN1082035A Inhibitors of hiv protease useful for the treatment of aids |
| 02/16/1994 | CN1081909A Methods and compositions for the treatment of diseases with interferon while reducing side effects |
| 02/16/1994 | CN1023803C Novel alpha-glucosidase inhibitors |
| 02/16/1994 | CN1023765C Sustained release matrix fomulations |
| 02/16/1994 | CN1023758C Antibiotic A 10255 complex and factors, process, microorganisms, and production thereof |
| 02/15/1994 | US5286856 Production of crystalline penem |
| 02/15/1994 | US5286717 Inhibitors for replication of retroviruses and for the expression of oncogene products |
| 02/15/1994 | US5286649 Pure culture of Amycolatopsis orientalis producing antibiotic |
| 02/15/1994 | US5286648 Culture of Streptosporangium carneum or mutants |
| 02/15/1994 | US5286488 Method for topical treatment of lesions associated with viral infections |
| 02/15/1994 | US5286484 Bactericides |
| 02/15/1994 | CA2101817A1 Pradimicin compounds |
| 02/15/1994 | CA1327096C Peptides corresponding to antigenic and immunogenic determinants of major neutralizing proteins of rotaviruses |
| 02/15/1994 | CA1327047C Complexes of tellurium and selenium derivatives |
| 02/15/1994 | CA1327046C Tellurium and selenium compounds for the induction of in vivo and in vitro production of cytokines |
| 02/15/1994 | CA1327002C Elaboration of host defense mediators into biological fluids by systemic dsrna treatment |
| 02/15/1994 | CA1327001C Topically active compositions of double-stranded rnas |
| 02/15/1994 | CA1327000C Antiviral therapy for hepatitis b |
| 02/15/1994 | CA1326999C Double-stranded rna correction of abnormalities in circulating immune complexes and monocyte function |
| 02/11/1994 | CA2103515A1 Hepatitis a virus vaccine |
| 02/10/1994 | DE4226279A1 Liponucleotide von Seco-Nucleosiden, deren Herstellung sowie deren Verwendung als antivirale Arzneimittel Liponucleotide Seco-nucleosides, their preparation and their use as antiviral drugs |
| 02/09/1994 | EP0582455A1 Benzoxazinones as inhibitors of HIV reverse transcriptase |
| 02/09/1994 | EP0582396A1 Taste-masking composition of bitter pharmaceutical agents |